Cargando…
Remdesivir in moderate to severe COVID-19: A matter of time?
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172330/ https://www.ncbi.nlm.nih.gov/pubmed/34089865 http://dx.doi.org/10.1016/j.phrs.2021.105711 |
| _version_ | 1783702522676903936 |
|---|---|
| author | Bonazzetti, Cecilia Giacomelli, Andrea Pavia, Martina Fusetti, Chiara Gerbi, Martina Petri, Francesco Poloni, Andrea Oreni, Letizia Ridolfo, Anna Lisa Antinori, Spinello |
| author_facet | Bonazzetti, Cecilia Giacomelli, Andrea Pavia, Martina Fusetti, Chiara Gerbi, Martina Petri, Francesco Poloni, Andrea Oreni, Letizia Ridolfo, Anna Lisa Antinori, Spinello |
| author_sort | Bonazzetti, Cecilia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8172330 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81723302021-06-03 Remdesivir in moderate to severe COVID-19: A matter of time? Bonazzetti, Cecilia Giacomelli, Andrea Pavia, Martina Fusetti, Chiara Gerbi, Martina Petri, Francesco Poloni, Andrea Oreni, Letizia Ridolfo, Anna Lisa Antinori, Spinello Pharmacol Res Letter to the Editor Published by Elsevier Ltd. 2021-08 2021-06-03 /pmc/articles/PMC8172330/ /pubmed/34089865 http://dx.doi.org/10.1016/j.phrs.2021.105711 Text en © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Bonazzetti, Cecilia Giacomelli, Andrea Pavia, Martina Fusetti, Chiara Gerbi, Martina Petri, Francesco Poloni, Andrea Oreni, Letizia Ridolfo, Anna Lisa Antinori, Spinello Remdesivir in moderate to severe COVID-19: A matter of time? |
| title | Remdesivir in moderate to severe COVID-19: A matter of time? |
| title_full | Remdesivir in moderate to severe COVID-19: A matter of time? |
| title_fullStr | Remdesivir in moderate to severe COVID-19: A matter of time? |
| title_full_unstemmed | Remdesivir in moderate to severe COVID-19: A matter of time? |
| title_short | Remdesivir in moderate to severe COVID-19: A matter of time? |
| title_sort | remdesivir in moderate to severe covid-19: a matter of time? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172330/ https://www.ncbi.nlm.nih.gov/pubmed/34089865 http://dx.doi.org/10.1016/j.phrs.2021.105711 |
| work_keys_str_mv | AT bonazzetticecilia remdesivirinmoderatetoseverecovid19amatteroftime AT giacomelliandrea remdesivirinmoderatetoseverecovid19amatteroftime AT paviamartina remdesivirinmoderatetoseverecovid19amatteroftime AT fusettichiara remdesivirinmoderatetoseverecovid19amatteroftime AT gerbimartina remdesivirinmoderatetoseverecovid19amatteroftime AT petrifrancesco remdesivirinmoderatetoseverecovid19amatteroftime AT poloniandrea remdesivirinmoderatetoseverecovid19amatteroftime AT oreniletizia remdesivirinmoderatetoseverecovid19amatteroftime AT ridolfoannalisa remdesivirinmoderatetoseverecovid19amatteroftime AT antinorispinello remdesivirinmoderatetoseverecovid19amatteroftime |